TRACON Pharmaceuticals Inc (NASDAQ:TCON)’s traded shares stood at 1.99 million during the last session, with the company’s beta value hitting 1.26. At the close of trading, the stock’s price was $2.29, to imply an increase of 33.92% or $0.58 in intraday trading. The TCON share’s 52-week high remains $41.00, putting it -1690.39% down since that peak but still an impressive 30.57% since price per share fell to its 52-week low of $1.59. The company has a valuation of $5.22M, with an average of 193.75K shares over the past 3 months.

TRACON Pharmaceuticals Inc (NASDAQ:TCON) trade information

After registering a 33.92% upside in the last session, TRACON Pharmaceuticals Inc (TCON) has traded red over the past five days. The stock hit a weekly high of 3.3700, jumping 33.92% in its intraday price action. The 5-day price performance for the stock is -23.92%, and -68.29% over 30 days. With these gigs, the year-to-date price performance is -34.61%.

TRACON Pharmaceuticals Inc (TCON) estimates and forecasts

Looking at statistics comparing TRACON Pharmaceuticals Inc share performance against respective industry, we note that the company has underperformed competitors. TRACON Pharmaceuticals Inc (TCON) shares are -26.65% down over the last 6 months, with its year-to-date growth rate lower than industry average at -81.82% against 12.80%.

TCON Dividends

TRACON Pharmaceuticals Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. TRACON Pharmaceuticals Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.